Mira Pharmaceuticals Inc (MIRA) Stock Price

1.185 ▼ -0.015 (-1.25%)
Open: 1.175 Vol: 0 Day's range: 1.17 - 1.19 Feb 09, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MIRA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.18▲ 1.18▲ 1.18▲ 1.18▲ 1.30▼
MA10 1.18▲ 1.19▼ 1.19▼ 1.23▼ 1.41▼
MA20 1.19▼ 1.18▲ 1.18▲ 1.33▼ 1.43▼
MA50 1.18▲ 1.19▼ 1.21▼ 1.43▼ 1.34▼
MA100 1.19▼ 1.25▼ 1.32▼ 1.43▼ 1.27▼
MA200 1.25▼ 1.36▼ 1.42▼ 1.40▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ 0.000▲ 0.004▲ -0.016▼ -0.042▼
RSI 50.991▲ 49.758▼ 48.336▼ 32.754▼ 40.633▼
STOCH 48.810     28.869     39.352     13.066▼ 22.467    
WILL %R -62.500     -62.500     -31.250     -84.290▼ -90.179▼
CCI -17.436     -41.602     16.949     -79.546     -172.950▼
Latest Filters Detected On MIRA
▼ GAP $MIRA Open Gap Down %2 Set Alert
Mira Pharmaceuticals Inc News
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
Tuesday, February 03, 2026 04:50 AM
Company to Participate in BIO Partnering Summit and Present Phase 1 Ketamir-2 Data at American Association for Cancer Research (AACR)Annual Meeting MIAMI, FLORIDA / ACCESS Newswire / February 3, 2026 ...
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
Friday, October 03, 2025 08:40 AM
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA’s advancing programs including Ketamir-2 and MIRA-55 MIAMI, FLORIDA / ACCESS Newswire / September ...
MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Wednesday, August 20, 2025 10:16 AM
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 MIAMI, FL / ACCESS Newswire / August 19, 2025 / MIRA Pharmaceuticals, Inc.
MIRA historical stock data
date open high low close volume
09/02/26 1.175 1.19 1.17 1.185 117,165
06/02/26 1.17 1.23 1.146 1.20 101,800
05/02/26 1.19 1.26 1.13 1.13 266,519
04/02/26 1.19 1.215 1.16 1.21 195,600
03/02/26 1.22 1.24 1.17 1.19 139,900
02/02/26 1.23 1.24 1.19 1.21 224,009
30/01/26 1.26 1.29 1.23 1.24 140,600
29/01/26 1.34 1.34 1.22 1.25 352,800
28/01/26 1.34 1.38 1.33 1.33 91,265
27/01/26 1.34 1.39 1.31 1.34 202,757
Quote Details
52wk Low:0.74
52wk High:2.45
Vol:0
Avg Vol(3m):3.1M
1Y Chng:+15.05%
1M Chng:-21.52%
Add to Watch List
More Information
Index US Composite
Market Cap. 47.32M